Risky Stem Cell Transplant Halts MS for Years

                                                                  

Autologous haematopoietic stem cell transplantation has been used to stop autoimmune processes in MS, although the treatment is not effective for every person.

Want to learn more about stem cell transplants? Here’s a list of nine articles about the subject you should take a look at.

Fortunately, research is always evolving and there is now an improved version of the technique which is showing extremely good results, with patients free of both the need for treatment and the risk of relapses for years on end — but the risk associated with the procedure is substantial.

What are the risks for MS patients and how does this treatment work?The current stem cell transplantation process for these patients  involves stem cells being collected from their own bone marrow before the patients are exposed to chemotherapy. This treatment suppresses the immune system, so that when the stem cells are injected back into a person, the immune system is reset to no longer attack the body.

But is this treatment option worth the risks for MS patients? Read more about this study, this treatment and the risks around it, here.

Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews